Cargando…

Platelets, Aspirin and Cardiovascular Disease

Detalles Bibliográficos
Autor principal:	Elwood, P. C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Royal College of Physicians of London 1976
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366446/ https://www.ncbi.nlm.nih.gov/pubmed/957271

Ejemplares similares

Eicosanoids in platelets and the effect of their modulation by aspirin in the cardiovascular system (and beyond)
por: Crescente, Marilena, et al.
Publicado: (2018)

Aspirin for the Primary Prevention of Cardiovascular Disease: Time for a Platelet-Guided Approach
por: Cofer, Lucas B., et al.
Publicado: (2022)

Aspirin for Prevention of Cardiovascular Disease
por: Mendy, Vincent L., et al.
Publicado: (2017)

Fifty years with aspirin and platelets
por: Patrono, Carlo
Publicado: (2022)

Aspirin for primary prevention of cardiovascular disease
por: Nansseu, Jobert Richie N., et al.
Publicado: (2015)

Aspirin for Primary Prevention of Cardiovascular Disease
por: Kim, Ji Hye, et al.
Publicado: (2019)

Association between renal function and platelet reactivity during aspirin therapy in elderly patients with atherosclerotic cardiovascular disease
por: Liang, Wenyi, et al.
Publicado: (2021)

Hepatocellular Carcinoma Prevention by Aspirin: Are Platelets the Link?
por: Nischalke, Hans Dieter, et al.
Publicado: (2021)

Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease
por: Pi, Lei, et al.
Publicado: (2018)

Platelet Reactivity and Response to Aspirin and Clopidogrel in Patients with Platelet Count Disorders
por: Kuliczkowski, Wiktor, et al.
Publicado: (2021)

Aspirin overutilization for the primary prevention of cardiovascular disease
por: VanWormer, Jeffrey J, et al.
Publicado: (2014)

Aspirin for primary prevention of cardiovascular disease in diabetes
por: Xing, Ying, et al.
Publicado: (2019)

Aspirin for the primary prevention of cardiovascular disease in the elderly
por: O’Sullivan, Jack W
Publicado: (2019)

Aspirin in the Modern Era of Cardiovascular Disease Prevention
por: Murphy, Ella, et al.
Publicado: (2021)

Aspirin in primary prevention of cardiovascular disease in diabetes
por: Papazafiropoulou, Athanasia K., et al.
Publicado: (2021)

Influence of Sex on Platelet Reactivity in Response to Aspirin
por: Friede, Kevin A., et al.
Publicado: (2020)

Inability to Reverse Aspirin and Clopidogrel-induced Platelet Dysfunction with Platelet Infusion
por: Cohn, Stephen M, et al.
Publicado: (2019)

Recovery Time of Platelet Function After Aspirin Withdrawal
por: Lee, Jeonghun, et al.
Publicado: (2014)

Clinical Use of Aspirin in Treatment and Prevention of Cardiovascular Disease
por: Dai, Yuxiang, et al.
Publicado: (2012)

Use of Aspirin and Statin as primary prevention for cardiovascular diseases
por: Alkhail, Bahaa Aba, et al.
Publicado: (2016)

Aspirin use for cardiovascular disease prevention in the uninsured population
por: Liu, Nina, et al.
Publicado: (2020)

Aspirin Delimits Platelet Life Span by Proteasomal Inhibition
por: Nayak, Manasa K., et al.
Publicado: (2014)

Circadian Rhythm of Cardiovascular Disease: The Potential of Chronotherapy With Aspirin
por: Buurma, Marleen, et al.
Publicado: (2019)

Aspirin for Primary Prevention of Cardiovascular Diseases: “WALTZ” with the Evidence
por: Dimitriadis, Kyriakos, et al.
Publicado: (2022)

Platelet Isoprostane Overproduction in Diabetic Patients Treated With Aspirin
por: Cangemi, Roberto, et al.
Publicado: (2012)

The Effects of Cyclosporine and Aspirin on Platelet Function in Normal Dogs
por: Thomason, J., et al.
Publicado: (2016)

Metabolomic Analysis of Platelets of Patients With Aspirin Non-Response
por: Chiang, Jiun-Yang, et al.
Publicado: (2019)

Effects of Aspirin and Prednisone on Platelet Function and Thromboxane Synthesis in Healthy Dogs
por: Thomason, John M., et al.
Publicado: (2019)

Mechanism of Improving Aspirin Resistance: Blood-Activating Herbs Combined With Aspirin in Treating Atherosclerotic Cardiovascular Diseases
por: Zhao, Yixi, et al.
Publicado: (2021)

Predictors of high on-aspirin platelet reactivity in elderly patients with coronary artery disease
por: Zhang, JW, et al.
Publicado: (2017)

Myeloproliferative Neoplasms and Aspirin: Does Increased Platelet Turnover Matter?
por: Koçak Göktürk, Ilgın, et al.
Publicado: (2023)

The Aspirin Foundation Scientific Conference: the history, the present state and the future of aspirin prophylaxis
por: Smith, Tom, et al.
Publicado: (2014)

Aspirin in the 21st century—common mechanisms of disease and their modulation by aspirin: a report from the 2015 scientific conference of the international aspirin foundation, 28 August, London, UK
por: Smith, Tom, et al.
Publicado: (2015)

Misuse of Aspirin and Associated Factors for the Primary Prevention of Cardiovascular Disease
por: Chen, Yinong, et al.
Publicado: (2021)

Challenging the “Divinity” of Aspirin Monotherapy for Secondary Prevention of Cardiovascular Disease
por: Spartalis, Michael, et al.
Publicado: (2023)

Correction: Aspirin Delimits Platelet Life Span by Proteasomal Inhibition
Publicado: (2014)

Comparison of Triple Anti-Platelet Therapy (Aspirin, Clopidogrel, and Cilostazol) and Double Anti-Platelet Therapy (Aspirin and Clopidogrel) on Platelet Aggregation in Type 2 Diabetic Patients Undergoing Drug-Eluting Stent Implantation
por: Yang, Tae-Hyun, et al.
Publicado: (2009)

Aspirin inhibits the production of proangiogenic 15(S)-HETE by platelet cyclooxygenase-1
por: Rauzi, Francesca, et al.
Publicado: (2016)

The Influence of Haemoglobin A1c Levels on Platelet Aggregation and Platelet Turnover in Patients with Coronary Artery Disease Treated with Aspirin
por: Neergaard-Petersen, Søs, et al.
Publicado: (2015)

Network reconstruction of platelet metabolism identifies metabolic signature for aspirin resistance
por: Thomas, Alex, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_dl3skn9f2855ud1hc86c9140s5